Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01093469 · ClinicalTrials.gov registry record · Phase 4
Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 39
- Enrollment target
NCT01093469 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 39 participants.
The verdict
NCT01093469, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy and cost effectiveness of Aquaphor Healing Ointment, Atopiclair and EpiCeram as a monotherapy in mild to moderate AD. The investigators hypothesize that no statistical difference will exist in the efficacy between an over-the-counter moisturizer, Aquaphor Healing Ointment, compared to prescription devices Atopiclair and EpiCeram in treating mild to moderate AD. Therefore, Aquaphor will be most cost-effective than Atopiclair or EpiCeram.
Interventions
- DRUG EpiCeram
- DRUG Atopiclair Nonsteroidal Cream
- OTHER Aquaphor Healing Ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01093469
The ClinicalTrials.gov registry entry for NCT01093469 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which EpiCeram is the first listed.
NCT01093469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01093469 about?
NCT01093469 is a clinical study titled "Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis". The purpose of this study is to compare the efficacy and cost effectiveness of Aquaphor Healing Ointment, Atopiclair and EpiCeram as a monotherapy in mild to moderate AD. The investigators hypothesize that no statistical difference will exist in the efficacy between an over-the-counter moisturizer,...
What is the current status of trial NCT01093469?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 39 participants. The study started on 2009-09. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01093469?
The interventions under investigation include: EpiCeram (DRUG), Atopiclair Nonsteroidal Cream (DRUG), Aquaphor Healing Ointment (OTHER).
Who is sponsoring clinical trial NCT01093469?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.